INCY vs VRTX: Which Stock is Better?
Side-by-side comparison of Incyte Corp and Vertex Pharmaceuticals Inc in 2026
INCY
Incyte Corp
$98.07
VRTX
Vertex Pharmaceuticals Inc
$474.27
Key Metrics Comparison
| Metric | INCY | VRTX | Winner |
|---|---|---|---|
| Market Cap | $19.52B | $120.46B | VRTX |
| P/E Ratio | 15.30 | 30.96 | INCY |
| EPS (TTM) | $6.41 | $15.32 | VRTX |
| Revenue Growth | 0.3% | 0.1% | INCY |
| Gross Margin | 52.9% | 53.7% | VRTX |
Analyze INCY
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INCY or VRTX a better investment?
Comparing INCY and VRTX: Incyte Corp has a market cap of $19.52B while Vertex Pharmaceuticals Inc has $120.46B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INCY and VRTX?
INCY (Incyte Corp) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INCY or VRTX?
Based on P/E ratios, INCY trades at a lower multiple (15.3x vs 31.0x).
Which is growing faster: INCY or VRTX?
INCY has higher revenue growth at 0.3% vs 0.1% for VRTX.
Which company is more profitable: INCY or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to 52.9% for INCY.
Which is the larger company: INCY or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $120.46B compared to $19.52B for INCY.
Should I buy INCY or VRTX in 2026?
Both INCY and VRTX have investment merit. INCY trades at $98.07 while VRTX trades at $474.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INCY and VRTX stock?
Key differences: Market Cap ($19.52B vs $120.46B), P/E Ratio (15.3x vs 31.0x), Revenue Growth (0.3% vs 0.1%), Gross Margin (52.9% vs 53.7%).